With an activist investor on board, is the Rentokil Initial share price set to bounce back?

News of an activist investor has sent the Rentokil Initial share price up 13%. And Stephen Wright thinks there might be more to come.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Passive and Active: text from letters of the wooden alphabet on a green chalk board

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

News that Nelson Peltz has been building a stake in Rentokil Initial (LSE:RTO) has caused the share price to jump 13%. But the stock is still 28% lower than it was a year ago. 

If Trian Partners – Peltz’s firm – can find ways to unlock significant shareholder value, the share price could have further to rise. So should investors look to buy the stock now?

Activist investing

Ordinary investors like me buy shares in companies because they like they way they’re run. With activist investing, it’s the opposite. 

Activists make investments in businesses they think could be run better and then try to make management listen. Sometimes it works, sometimes it doesn’t. 

Most recently, Nelson Peltz showed up at Disney with a list of proposals. These included reducing losses from the streaming division and working out who the next CEO might be.

Trian’s bid to win a seat on the board failed, but shareholders – including Peltz – did pretty well. The stock went from around $88 to $120 during the activist’s time as an investor.

What’s wrong with Rentokil?

The latest news is that Trian has turned its attention to Rentokil. Things hadn’t been going well with the stock, so what does Peltz want the company to do?

It’s not yet clear. But one idea might be for the company to join the seemingly unending parade of businesses delisting from the London Stock Exchange and moving to New York.

The idea isn’t crazy – shares listed in New York trade at much higher price-to-earnings (P/E) multiples than their UK counterparts. And Rentokil does most of its business in the US.

When Indivior announced that it was considering this idea back in February, its stock jumped 26%. So could something similar be on the cards for Rentokil?

Should I buy?

The latest news is annoying for me – I said in an article last week that I thought Rentokil shares looked attractive near their 52-week lows. A 13% jump makes things a lot less clear.

With a view to buying the stock, I don’t want the share price higher. And I don’t think there’s much wrong with the underlying business. 

The company has carved out a dominant position in a growing industry. It’s working on bringing down its debt after a big acquisition, but things are moving in the right direction.

Activist involvement brings a new risk to the equation, though. If Peltz fails to make an impact – for whatever reason – the stock could go back to where it was.

Active vs passive investing

Trian’s involvement in Rentokil changes the investment picture. Investors need to consider how likely it is that Peltz will bring about change and what the outcome will be either way. 

That’s a much more complicated equation. And a higher share price makes it more difficult to view the stock as a buying opportunity right now.

All of that means I need to have another think about whether or not to buy Rentokil shares. But at least I’m in good company with my view that it was a bargain before.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Stephen Wright has positions in Walt Disney. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

3 high-yield dividend shares to consider buying for a retirement portfolio

Dividend shares can provide retirees with regular passive income in their golden years. Our writer picks out three with yields…

Read more »

Investing Articles

Tesla stock has halved. Could it now double – or halve again?

After a wild few months for Tesla stock, Christopher Ruane weighs some pros and cons of the investment case. Could…

Read more »

Investing Articles

Does it make sense to start buying shares as the stock market wobbles?

Does a rocky stock market make for a good or bad time to start buying shares? This writer reckons it…

Read more »

Passive income text with pin graph chart on business table
Investing Articles

£15k of passive income a year? It’s possible with the right dividend strategy!

To figure out how much dividends are needed for a lucrative passive income stream, investors must understand which strategies get…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

As US markets wobble, I’m listening to Warren Buffett!

The long career of billionaire investor Warren Buffett has included plenty of market turbulence. Here's what our writer's learnt from…

Read more »

UK money in a Jar on a background
Investing Articles

5 shares yielding over 5% to consider for a SIPP

Christopher Ruane introduces a handful of FTSE 100 and FTSE 250 shares he thinks an income-focussed SIPP investor should consider.

Read more »

Investing Articles

Here’s how an investor could invest a £20k ISA to target £1,500 of passive income per year

Can a £20,000 ISA throw off close to £30 per week on average of passive income when invested in blue-chip…

Read more »

Investing Articles

As gold hits $3,000, this FTSE 100 stock is primed for blast off

As Western institutions scramble to get as much gold as they can lay their hands on, Andrew Mackie believes this…

Read more »